Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Bluebird, Crispr, Dyadic, Essa, Genequantum, Ginkgo, ICER, Imaginab, Insilico, Intercept, J&J, Leucid, Madrigal, Merck & Co., Microbiota, Pyramid, Tiziana, Vertex, Xenetic.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aeglea, Altamira, Atea, Avalyn, Cellectis, Junshi, Kineta, Leap, Merck KGaA, Mymd, Novaliq, Onl, Panbela, Scineuro, Sirnaomics, Verrica.

Biopharmas raising money in public or private financings, including: Biomea, Mirum Regulus.

New hires and promotions in the biopharma industry, including: .

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Avation Medical, Magnolia Medical, Nova Eye Medical.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Ablative Solutions, Agilent, Freenome, Pathai, Raisonance.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: GC Genome.

Med-tech firms raising money in public or private financings, including: Milkmate Products, Oncosec Medical, Overwater Ventures, Scene Health.

New hires and promotions in the med-tech industry, including: AVS, Bausch + Lomb, Biocartis, Cutera, Emvenio, Gynesonics, Oncohealth.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Acurx, Biosyngen, Boan, Bone, HRA, Nova Mentis, Regenxbio, Sarepta, Takeda, Telix, Vertex.